Abstract
Chapter 99 discusses the design and implementation of a platform for genomic medicine in Mexico, including implications for healthcare, ethical, legal and social implications, human genetics and genomic sciences in Mexico, ancestry of the Mexican population, a strategy to establish a national institute of genomic medicine, the foundation and initial development of INMEGEN, its board of trustees and its alignment with federal programs, INMEGEN work and achievements between 2004–2009, academic activities and technological infrastructure, and the Mexican genome diversity project.